Skip to main content
GCTK
NASDAQ Industrial Applications And Services

Stockholders Clear Path for Nasdaq-Compliant Share Issuances in ELOC and Bridge Financing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$2.4
Mkt Cap
$1.955M
52W Low
$2.26
52W High
$212.1
52W Position info
6.2% above low
Off High info
99% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

GCTK is trading near its 52-week low of $2.26 (6.2% above the low) on light trading volume (0.2× avg).

Summary

Stockholders approved share issuances for the ELOC and bridge financing at the September 11 special meeting, and the company amended its common warrants to require stockholder approval before exercise.


Key Events · Corporate Governance and Compliance · GCTK

  • Stockholder Approval Obtained

    Both Nasdaq Listing Rule 5635(d) proposals were approved at the September 11, 2026 special meeting: Proposal 1 (ELOC with White Lion Capital) received 3,101,374 votes for and Proposal 2 (Bridge Financing) received 3,106,894 votes for.

  • Warrant Exercise Conditioned on Approval

    The company amended its common warrants dated August 4, 2026 to prohibit any exercise until stockholder approval is obtained for all warrant shares under Nasdaq Listing Rule 5635(d).

  • Quorum and Turnout

    Of 10,578,822 shares outstanding, 3,661,960 votes (34.61%) were represented at the meeting, constituting a quorum.

  • Financing Context

    This vote follows the $4.5M cash raise via $11.6M of convertible notes disclosed on September 11, 2026, and the company's going-concern warning in its Q2 10-Q.


Analysis · GCTK · Industrial Applications And Services

At the September 11 special meeting, stockholders approved both Nasdaq Listing Rule 5635(d) proposals, enabling the company to issue shares under its $50M equity line with White Lion Capital and upon conversion of its bridge notes. The company also amended its common warrants to require stockholder approval before any exercise, a condition that protects Nasdaq compliance but delays potential dilution. This vote removes a key regulatory hurdle for the company's survival financing, which is critical given its going-concern status and cash crisis disclosed in the Q2 10-Q.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GCTK was trading at $2.40 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2M. The 52-week trading range was $2.26 to $212.10. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GCTK - Latest Insights

GCTK
Sep 28, 2026, 5:29 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.78
Real-time Price: $1.18 info
Change: -$0.5999 (-34%) info
Market Cap: $1.232M info
GCTK
Sep 24, 2026, 5:25 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $2.65
Real-time Price: $1.18 info
Change: -$1.47 (-55%) info
Market Cap: $1.232M info
GCTK
Sep 24, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.65
Real-time Price: $1.18 info
Change: -$1.47 (-55%) info
Market Cap: $1.232M info
GCTK
Sep 24, 2026, 8:45 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $4.11
Real-time Price: $1.18 info
Change: -$2.93 (-71%) info
Market Cap: $1.232M info
GCTK
Sep 18, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.47
Real-time Price: $1.18 info
Change: -$1.29 (-52%) info
Market Cap: $1.232M info